Prostamax, Testagen, and Vesilute make up the complete Urogenital panel among the short peptide bioregulators sold on the site, the one system not represented in the Bioregulator Core Panel, each studied with a distinct organ-level association within the urogenital system.
HPLC certified
Independent analysis
Highest standard
Full traceability
The Bioregulator Urogenital kit bundles Prostamax 20mg, Testagen 20mg, and Vesilute 20mg, the complete three-peptide Urogenital panel, and the one system not represented in the Bioregulator Core Panel.
Short peptide bioregulators are a research category built on tissue specificity, each compound is studied in relation to a particular organ or tissue system rather than acting as a broad-spectrum agent, an approach that traces back to peptide bioregulation research programs studying tissue-specific extracts and their synthesized peptide equivalents.
Prostamax is studied with a closer association to prostate tissue, Testagen to testicular tissue, and Vesilute to bladder tissue. Each vial ships individually labeled and independently HPLC-verified. This product is intended strictly for laboratory research use only and is not approved for human consumption.
Prostamax, Testagen, and Vesilute make up the complete Urogenital panel among the short peptide bioregulators sold on the site, the one system not represented in the Bioregulator Core Panel, each studied with a distinct organ-level association within the urogenital system.
Short peptide bioregulators are a research category built on tissue specificity, each compound is studied in relation to a particular organ or tissue system rather than acting as a broad-spectrum agent, an approach that traces back to peptide bioregulation research programs studying tissue-specific extracts and their synthesized peptide equivalents.
This panel represents the Urogenital system, the only one of the seven system categories not included in the Bioregulator Core Panel, making this the dedicated kit for researchers whose work specifically involves urogenital-tissue bioregulator research.
| Vial | Peptide | Strength | System |
|---|---|---|---|
| Vial 1 | Prostamax | 20mg | Urogenital, prostate-tissue research. |
| Vial 2 | Testagen | 20mg | Urogenital, testicular-tissue research. |
| Vial 3 | Vesilute | 20mg | Urogenital, bladder-tissue research. |
Prostamax is studied with a research association more specific to prostate tissue, while Testagen is studied with a research association more specific to testicular tissue. Both represent components of the male reproductive system, studied as related but anatomically distinct tissue types within urogenital bioregulator research. The two compounds are frequently referenced together specifically because prostate and testicular tissue are functionally interconnected within male reproductive-system physiology.
Vesilute is studied with a research association more specific to bladder tissue, rounding out the three organ-level associations within this system. The bladder sits functionally adjacent to the reproductive-system organs Prostamax and Testagen address, which is why all three are grouped under the single Urogenital system category rather than split further.
The Bioregulator Core Panel was built to give researchers a representative peptide from six of the seven bioregulator systems in a single, manageable six-vial kit, leaving Urogenital as the one system requiring its own dedicated purchase. Researchers whose work specifically concerns prostate, testicular, or bladder-tissue bioregulator research go directly to this three-peptide panel rather than needing the Core Panel plus a separate individual vial.
Together with the six systems already represented in the Core Panel, this Urogenital panel completes coverage of all seven bioregulator system categories sold on the site. Researchers who purchase both the Core Panel and this Urogenital panel effectively assemble the same seven-system breadth as the sixteen-peptide Full Master Set, though at a different vial count and price point depending on which systems are actually needed for a given protocol. Urogenital-tissue bioregulator research, like the other six system categories, is organized around the same tissue-specificity principle that defines this entire research category.
For breadth across the other six systems instead, see the Bioregulator Core Panel. For the complete sixteen-peptide set across all seven systems, see the Bioregulator Full Master Set. Browse the full Peptide Bundles collection for the complete lineup.
Each of the three vials ships individually labeled with compound name, strength, and batch lot number, none are pre-mixed. Every vial is independently verified through HPLC before batch release, with Certificates of Analysis available per component on request.
This product is intended strictly for laboratory research use only. It is not approved for human consumption, therapeutic application, or diagnostic purposes.
Telomerase enzyme explained: how TERT and TERC maintain telomeres, why it matters in aging and cancer research, plus RUO peptide sourcing. Read the guide.
KLOW peptide research blend is drawing attention across California's research community. Discover its composition, COA basics, and current evidence limits.
Learn what a peptide bond is, how it forms through dehydration synthesis, and why its structure matters for research peptides. Read the full guide now.
(faqs)
